liver-fibrosis

GoogleDeepMind collaborated with global scientific experts to evaluate an AI system that identified new targets for liver fibrosis and fresh approaches to ALS, digesting decades of research.

DeepMind's Co-Scientist AI helped identify two repurposed medicines that block liver fibrosis in lab tests, including a cancer drug that blocked 91% of a damage response, outperforming human expert selections.